Recurrent group B streptococcal disease in infants: Who should receive rifampin?
Jane T. Atkins(Methodist Children’s Hospital), Carol J. Baker(Baylor College of Medicine), Gloria P. Heresi(The University of Texas Health Science Center at Houston), Teresa M. Coque(Instituto Cajal)
Cited by 31
Related Papers
Defining and combating antibiotic resistance from One Health and Global Health perspectives
|Nature Microbiology|2019|1.2k
The CTX-M β-lactamase pandemic
|Current Opinion in Microbiology|2006|1.1k
What is a resistance gene? Ranking risk in resistomes
|Nature Reviews Microbiology|2014|1k
CTX-M: changing the face of ESBLs in Europe
|Journal of Antimicrobial Chemotherapy|2006|923
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
|Eurosurveillance|2008|800